FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224988894> ?p ?o ?g. }

• W4224988894 endingPage "287" @default.
• W4224988894 startingPage "278" @default.
• W4224988894 abstract "Abstract Objective The present study aimed to identify possible phenotypic changes in 4T1 (murine mammary adenocarcinoma) cells in vitro, including viability, HER-2 (human epidermal growth factor receptor-type 2) expression, and metastatic potential, after treatment with Carcinosinum in different homeopathic dilutions (12cH, 30cH, 200cH) shaken mechanically in pure, sterile, water from a commercial stock dilution. Methods Treated cells were cultured in R10 medium, using 24-well plates, 105 cells per well, and treated with vehicle, Carcinosinum 12cH, 30cH or 200cH; untreated cells were used as the baseline control. After 24 hours of treatment, the percentage of apoptotic cells was analyzed by annexin V. Cell morphology was evaluated by microscopy after hematoxylin-eosin and Giemsa staining, whilst HER-2 expression was assessed using immunocytochemistry. The metastatic potential was determined by the expression and activity of the enzyme matrix metalloproteinase 9 (MMP-9) using zymography. The cytokine profile was established using the cytometric bead array method. Result Treatment of 4T1 cells in vitro with Carcinosinum 30cH produced an increase in the number of annexin V-positive cells (apoptosis) and decreased expression of proactivated MMP-9. Cells treated with Carcinosinum 200cH presented hyper-expression of HER-2 on the plasma membrane, identified by immunocytochemistry. There were no differences in cytokine production among treatments. Conclusion The data show promising results for Carcinosinum 30cH in vitro, but in vivo studies are also required to evaluate the role of tumor microenvironment in its effects." @default.
• W4224988894 created "2022-04-28" @default.
• W4224988894 creator A5011898661 @default.
• W4224988894 creator A5050051508 @default.
• W4224988894 creator A5055279762 @default.
• W4224988894 creator A5055775127 @default.
• W4224988894 creator A5059269851 @default.
• W4224988894 creator A5054166148 @default.
• W4224988894 date "2022-04-27" @default.
• W4224988894 modified "2023-09-29" @default.
• W4224988894 title "Phenotypic Changes in Mammary Adenocarcinoma (4T1) cells In Vitro after Treatment with Carcinosinum" @default.
• W4224988894 cites W1969524807 @default.
• W4224988894 cites W1974384889 @default.
• W4224988894 cites W2004232045 @default.
• W4224988894 cites W2007413201 @default.
• W4224988894 cites W2011716233 @default.
• W4224988894 cites W2025401266 @default.
• W4224988894 cites W2033278321 @default.
• W4224988894 cites W2048349075 @default.
• W4224988894 cites W2052467200 @default.
• W4224988894 cites W2053436522 @default.
• W4224988894 cites W2074353390 @default.
• W4224988894 cites W2087436801 @default.
• W4224988894 cites W2094755758 @default.
• W4224988894 cites W2112727616 @default.
• W4224988894 cites W2114605941 @default.
• W4224988894 cites W2117692326 @default.
• W4224988894 cites W2131170195 @default.
• W4224988894 cites W2146470803 @default.
• W4224988894 cites W2150295774 @default.
• W4224988894 cites W2156139391 @default.
• W4224988894 cites W2249212496 @default.
• W4224988894 cites W2570443653 @default.
• W4224988894 cites W2576315334 @default.
• W4224988894 cites W2618839716 @default.
• W4224988894 cites W3038048939 @default.
• W4224988894 cites W3115296601 @default.
• W4224988894 cites W2091051024 @default.
• W4224988894 doi "https://doi.org/10.1055/s-0041-1740967" @default.
• W4224988894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35477183" @default.
• W4224988894 hasPublicationYear "2022" @default.
• W4224988894 type Work @default.
• W4224988894 citedByCount "1" @default.
• W4224988894 countsByYear W42249888942022 @default.
• W4224988894 crossrefType "journal-article" @default.
• W4224988894 hasAuthorship W4224988894A5011898661 @default.
• W4224988894 hasAuthorship W4224988894A5050051508 @default.
• W4224988894 hasAuthorship W4224988894A5054166148 @default.
• W4224988894 hasAuthorship W4224988894A5055279762 @default.
• W4224988894 hasAuthorship W4224988894A5055775127 @default.
• W4224988894 hasAuthorship W4224988894A5059269851 @default.
• W4224988894 hasConcept C109523444 @default.
• W4224988894 hasConcept C142724271 @default.
• W4224988894 hasConcept C150903083 @default.
• W4224988894 hasConcept C153911025 @default.
• W4224988894 hasConcept C154488023 @default.
• W4224988894 hasConcept C16685009 @default.
• W4224988894 hasConcept C177430391 @default.
• W4224988894 hasConcept C185592680 @default.
• W4224988894 hasConcept C190283241 @default.
• W4224988894 hasConcept C202751555 @default.
• W4224988894 hasConcept C203014093 @default.
• W4224988894 hasConcept C207001950 @default.
• W4224988894 hasConcept C2778690821 @default.
• W4224988894 hasConcept C35866371 @default.
• W4224988894 hasConcept C54355233 @default.
• W4224988894 hasConcept C553184892 @default.
• W4224988894 hasConcept C55493867 @default.
• W4224988894 hasConcept C71924100 @default.
• W4224988894 hasConcept C81885089 @default.
• W4224988894 hasConcept C86803240 @default.
• W4224988894 hasConcept C88634738 @default.
• W4224988894 hasConceptScore W4224988894C109523444 @default.
• W4224988894 hasConceptScore W4224988894C142724271 @default.
• W4224988894 hasConceptScore W4224988894C150903083 @default.
• W4224988894 hasConceptScore W4224988894C153911025 @default.
• W4224988894 hasConceptScore W4224988894C154488023 @default.
• W4224988894 hasConceptScore W4224988894C16685009 @default.
• W4224988894 hasConceptScore W4224988894C177430391 @default.
• W4224988894 hasConceptScore W4224988894C185592680 @default.
• W4224988894 hasConceptScore W4224988894C190283241 @default.
• W4224988894 hasConceptScore W4224988894C202751555 @default.
• W4224988894 hasConceptScore W4224988894C203014093 @default.
• W4224988894 hasConceptScore W4224988894C207001950 @default.
• W4224988894 hasConceptScore W4224988894C2778690821 @default.
• W4224988894 hasConceptScore W4224988894C35866371 @default.
• W4224988894 hasConceptScore W4224988894C54355233 @default.
• W4224988894 hasConceptScore W4224988894C553184892 @default.
• W4224988894 hasConceptScore W4224988894C55493867 @default.
• W4224988894 hasConceptScore W4224988894C71924100 @default.
• W4224988894 hasConceptScore W4224988894C81885089 @default.
• W4224988894 hasConceptScore W4224988894C86803240 @default.
• W4224988894 hasConceptScore W4224988894C88634738 @default.
• W4224988894 hasIssue "04" @default.
• W4224988894 hasLocation W42249888941 @default.
• W4224988894 hasLocation W42249888942 @default.
• W4224988894 hasOpenAccess W4224988894 @default.
• W4224988894 hasPrimaryLocation W42249888941 @default.

• next